SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
ZIOPHARM Oncology, Inc. Presents Systemic, DNA/Cell Plasmid Therapy Showing Long-Term Persistence and Anti-Tumor Effects at EORTC-National Cancer Institute-American Association for Cancer Research Meeting